Pipeline surveillance, trial tracking and conference intelligence for the teams bringing new cancer therapies to patients.
Clear, curated and timely, so commercial, medical and R&D teams act on what matters.
Continuous monitoring of trials, regulatory actions, publications and competitor moves, delivered in digestible updates.
On-the-ground insights and rapid-turnaround summaries from the meetings that shape your market.
Primary and secondary research tailored to your pipeline questions and launch timelines.
Deep, specialized coverage across the areas you compete in.
Analysis and perspective from our team.
CROs and cancer centers face different questions than sponsors, but the same intelligence advantage applies. Here is how to use CI to win studies and place trials.
Read more →Treatment algorithms show where each therapy sits in the patient journey. Learn how to build and maintain one, and how it informs launch and development decisions.
Read more →A practical framework for tracking oncology pipelines: what to record, how often to update, and how to rank competitor threats.
Read more →Talk to our team about how Oncology CI can support your next decision.
Request Info